Biocatalysis

Physics / mechanism

Biocatalysis uses enzymes, either isolated or held inside living cells, to run chemical transformations under mild aqueous conditions in place of petroleum-derived reagents and high-energy synthetic routes. The reaction specificity comes from the enzyme active site, so selectivity is set by protein sequence and structure rather than by process conditions. This makes enzyme discovery and engineering the rate-limiting step: better biocatalysts mean higher turnover, broader substrate scope, and tolerance of industrial temperature, pH and solvent conditions.

Two implementation modes exist. In isolated-enzyme catalysis the protein is purified and used as a reagent or immobilised catalyst. In whole-cell biocatalysis the host organism expresses the enzyme and supplies cofactors and precursor flux from its own metabolism. A recent demonstration of the latter used recombinant E. coli expressing tyrosinase to synthesise melanin and deposit it directly onto textile substrates, collapsing the conventional pigment synthesis, extraction, purification and application sequence into a single in situ step. The stated motivation is that natural pigments are biodegradable but suffer limited availability, batch variability and geographical dependence, while microbial biosynthesis is controllable and decoupled from environmental fluctuation.

Key parameters for any biocatalytic process are therefore enzyme class (the tyrosinase example sits in the oxidoreductase family), host expression level, cofactor regeneration, substrate loading, and whether product recovery is required at all. In situ deposition schemes trade away the ability to purify the product for a large reduction in unit operations, and the characterisation burden shifts to spectroscopic confirmation of the product on the substrate, with near-infrared and Raman spectroscopy used as the analytical handles in the melanin dyeing work.

Competitive landscape

The commercial expression of biocatalysis today is the industrial enzymes market, sized by Fortune Business Insights at USD 7.88bn in 2025, rising to USD 8.33bn in 2026 and USD 13.54bn by 2034 at a 6.25% CAGR, with cross-source estimates spanning USD 7.9 to 8.6bn for 2025 at 6.2 to 7.4% CAGR ref. Carbohydrases lead by enzyme type at USD 2.92bn in 2025 and microorganisms dominate as the production source at USD 7.08bn, indicating that fermentation-derived enzymes rather than plant or animal extracts are the default supply route ref. Application demand is concentrated in food and beverage (USD 2.04bn in 2025), with nutraceuticals the fastest-growing segment at 8.42% CAGR, and further pull from bioethanol, textiles, detergents, paper and pulp, feed and water treatment ref.

For anyone selling into this field, the distinction between the enzyme market and the enzyme-discovery toolchain matters. The headline figure bounds the value of the chemistry that better screening could unlock; the served market for screening instruments bought by enzyme-engineering companies is much smaller and harder to size ref.

Evidence base

Frontier (open questions)

Synthesised 2026-08-31 from 2 KB sources by the resynth pipeline; citations are KB source slugs.

Recent mentions